315
Participants
Start Date
October 31, 2025
Primary Completion Date
February 28, 2026
Study Completion Date
April 30, 2026
emodepside (BAY 44-4400)
Treatment with single dose of oral 15 mg emodepside
matching placebo of emodepside
Treatment with single dose of oral emodepside matching placebo
Mebendazole
Treatment with 100 mg mebendazole orally administered b.i.d. for 3 days
similar placebo to mebendazole
Treatment with mebendazole similar placebo orally administered b.i.d. for 3 days
Public Health Laboratory - Ivo de Carneri (PHL-IdC), Chake Chake
Collaborators (1)
Public Health Laboratory Ivo de Carneri
OTHER
Bayer
INDUSTRY
Silicon Valley Community Foundation
OTHER
Swiss Tropical & Public Health Institute
OTHER